Tom Juhani Rönnlund

Director/Board Member chez REDWOOD PHARMA AB

Profil

Tom Juhani Rönnlund is currently the Chief Executive Officer at Navamedic AB, the Chief Executive Officer & Director at Observe Medical International AB, the Director at Bonnier News Business AB, the Director at The International Probiotics Association, an Independent Director at Redwood Pharma AB, a Director at Blueroot Health, Inc., a Director at Bonnier Healthcare Sweden AB, an Independent Director at ProstaLund AB, and the Chief Commercial Officer at Surgify Medical Oy.
In the past, Mr. Rönnlund served as the Chief Executive Officer at Probi AB from 2019 to 2022, the Chief Executive Officer at Navamedic ASA from 2015 to 2018, and as a Non-Executive Director at BLIS Technologies Ltd.
from 2021 to 2023.
He also held positions such as Business Unit Director at Eli Lilly Danmark A and Eli Lilly Sweden AB, Country Manager at Bristol-Myers Squibb AB, and General Manager at IMS Health Norway AS.
Mr. Rönnlund completed his undergraduate studies and obtained an MBA from the University of Stockholm.

Postes actifs de Tom Juhani Rönnlund

Sociétés	Poste	Début
REDWOOD PHARMA AB	Director/Board Member	01/06/2023
PROSTALUND AB	Director/Board Member	12/10/2023
Surgify Medical Oy	Corporate Officer/Principal	01/06/2023
Blueroot Health	Director/Board Member	-
The International Probiotics Association	Director/Board Member	-
Bonnier Healthcare Sweden AB	Director/Board Member	01/01/2015
Bonnier News Business AB	Director/Board Member	-
Navamedic AB	Chief Executive Officer	-
Observe Medical International AB	Chief Executive Officer	-

Anciens postes connus de Tom Juhani Rönnlund

Sociétés	Poste	Fin
░░░░ ░░░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-
░░░░░░░░░░░░░ ░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

Formation de Tom Juhani Rönnlund

University of Stockholm

Masters Business Admin